These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 469865)

  • 1. Fibrocystic disease of the breast.
    Leis HP; Kwon CS
    J Reprod Med; 1979 Jun; 22(6):291-6. PubMed ID: 469865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of cellular DNA in the study of the relations between fibrocystic disease of the breast and breast cancer].
    Lazzari G; Lamarca S
    Arch Sci Med (Torino); 1977; 134(2):137-44. PubMed ID: 869700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
    Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous mastectomy and fibrocystic disease of the breast.
    Pennisi VR
    Clin Plast Surg; 1976 Apr; 3(2):205-16. PubMed ID: 1261177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign breast disease. Diagnosis and treatment.
    Wilcox PM; Ettinger DS
    Prim Care; 1977 Dec; 4(4):739-54. PubMed ID: 243917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic mastectomy for precancerous and high-risk lesions of the breast.
    Ariyan S
    Can J Surg; 1985 May; 28(3):262-4, 266. PubMed ID: 3995424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrocystic mastopathy and cancer of the breast. About 111 cases].
    Beyrouti MI; Beyrouti R; Khabir A; Ben Amar M; Frikha F; Dhieb N; Damak D; Abid M; Affes N; Boujelben S; Frikha M
    Tunis Med; 2006 Oct; 84(10):626-31. PubMed ID: 17193854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
    Shirley SE
    West Indian Med J; 1999 Dec; 48(4):173-8. PubMed ID: 10639833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrocystic mastopathy and risk of cancer from the viewpoint of the pathologist].
    Guski H
    Z Arztl Fortbild (Jena); 1991 Oct; 85(20):970-2. PubMed ID: 1776287
    [No Abstract]   [Full Text] [Related]  

  • 10. Benign breast disease.
    Hamed H; Fentiman IS
    Int J Clin Pract; 2001 Sep; 55(7):461-4. PubMed ID: 11594256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Some aspects of fibrocystic breast disease].
    Mizia-Stec K; Zych F
    Pol Merkur Lekarski; 1997 May; 2(11):303-6. PubMed ID: 9377675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrocystic change and fibrocystic disease of the breast.
    Drukker BH; deMendonca WC
    Obstet Gynecol Clin North Am; 1987 Sep; 14(3):685-702. PubMed ID: 3323971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspiration of breast cysts.
    Wilson ND
    Am Surg; 1972 Sep; 38(9):509-13. PubMed ID: 5070035
    [No Abstract]   [Full Text] [Related]  

  • 15. [Counseling protocol for early cancer detection at the Women's Health Center in Ruma].
    Nedić B; Ravić J; Loncar S; Cuk D
    Med Pregl; 1999; 52(3-5):162-4. PubMed ID: 10518403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous mastectomy and breast replacement: its role in the treatment of benign, premalignant, and malignant breast disease.
    Blevins PK
    Am Surg; 1981 Jul; 47(7):281-6. PubMed ID: 7258836
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of the importance of fibrocystic mastopathy as a precancerous lesion].
    Napolitano A; Di Curzio B; Stella S
    Ann Ital Chir; 1973-1974; 48(3-4):265-76. PubMed ID: 4378000
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for fibrocystic breast disease and its histopathologic components.
    Berkowitz GS; Kelsey JL; LiVolsi VA; Holford TR; Merino MJ; Ort S; O'Connor TZ; White C
    J Natl Cancer Inst; 1985 Jul; 75(1):43-50. PubMed ID: 3859695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a comprehensive breast center.
    Harness JK; Bartlett RH; Saran PA; Bord MA; Noble WC
    Am Surg; 1987 Aug; 53(8):419-23. PubMed ID: 3605861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.